Deutsche Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-766
Closed -$49K 5364
2019
Q1
$49K Sell
766
-963
-56% -$64K ﹤0.01% 4563
2018
Q4
$108K Sell
1,729
-214
-11% -$15K ﹤0.01% 4187
2018
Q3
$150K Sell
1,943
-750
-28% -$56.6K ﹤0.01% 4350
2018
Q2
$191K Buy
2,693
+1,496
+125% +$106K ﹤0.01% 4307
2018
Q1
$90K Sell
1,197
-5,522
-82% -$439K ﹤0.01% 4547
2017
Q4
$481K Buy
6,719
+1,465
+28% +$111K ﹤0.01% 3620
2017
Q3
$425K Sell
5,254
-2,345
-31% -$179K ﹤0.01% 3507
2017
Q2
$536K Buy
7,599
+943
+14% +$62.8K ﹤0.01% 3409
2017
Q1
$450K Buy
6,656
+3,208
+93% +$226K ﹤0.01% 3137
2016
Q4
$246K Sell
3,448
-2,266
-40% -$168K ﹤0.01% 3560
2016
Q3
$451K Buy
5,714
+1,575
+38% +$128K ﹤0.01% 3253
2016
Q2
$344K Sell
4,139
-4,560
-52% -$405K ﹤0.01% 3488
2016
Q1
$798K Sell
8,699
-4,558
-34% -$411K ﹤0.01% 2950
2015
Q4
$1.34M Sell
13,257
-8,509
-39% -$885K ﹤0.01% 2692
2015
Q3
$2.13M Buy
21,766
+6,795
+45% +$755K ﹤0.01% 2440
2015
Q2
$1.75M Buy
14,971
+11,521
+334% +$1.26M ﹤0.01% 2562
2015
Q1
$337K Sell
3,450
-3,325
-49% -$338K ﹤0.01% 3510
2014
Q4
$638K Buy
6,775
+2,532
+60% +$262K ﹤0.01% 3515
2014
Q3
$451K Buy
4,243
+3,343
+371% +$327K ﹤0.01% 3575
2014
Q2
$73K Hold
900
﹤0.01% 4742
2014
Q1
$10K Sell
900
-8,440
-90% -$662K ﹤0.01% 5033
2013
Q4
$1K Buy
9,340
+1,499
+19% +$104K ﹤0.01% 5266
2013
Q3
$4K Sell
7,841
-1,349
-15% -$80.6K ﹤0.01% 5211
2013
Q2
$19K Buy
+9,190
New +$479K ﹤0.01% 4782

Other funds holding GILD

Deutsche Bank's GILD Position: Q1 2026 in Review

Deutsche Bank increased its Gilead Sciences (GILD) stake by 0.46% in Q1 2026, buying an estimated $4M and bringing the position to 6,222,328 shares worth $867M. The position accounts for 0.29% of the portfolio, ranked #71.

Deutsche Bank first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.16B in Q4 2015. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Deutsche Bank held 6,222,328 shares of Gilead Sciences worth $867M as of Q1 2026.
  • Deutsche Bank bought 28,574 Gilead Sciences shares in Q1 2026, an estimated $4M.
  • Gilead Sciences made up 0.29% of Deutsche Bank's portfolio in Q1 2026, its #71 holding.
  • Deutsche Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
  • Deutsche Bank's Gilead Sciences position peaked at $1.16B in Q4 2015.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.